
|Articles|February 1, 2004
Phakic IOL delivers good results in FDA trial for myopia
Anaheim, CA-An increasing number of IOLs are being developed to achieve improved vision in patients with extreme levels of myopia. One such lens is the Artisan/ Verisyse phakic IOL (Ophtec USA/Advanced Medical Optics), said R. Doyle Stulting, MD, PhD, who reported the results of the FDA clinical study here at the American Academy of Ophthalmology annual meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















